SCHEMBL10170534

SCHEMBL10170534

CCc1ccc2c(c1)C(=O)NC1(CCN(C(=O)c3cc(OC)c4cccc(OC)c4n3)CC1)O2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 8/20 0.50
ACACA Q13085 2/20 0.50
P2RY12 Q9H244 1/20 0.39
HDAC3 O15379 4/20 0.38
HDAC4 P56524 4/20 0.38
HDAC1 Q13547 4/20 0.38
HDAC7 Q8WUI4 4/20 0.38
HDAC2 Q92769 4/20 0.38
HDAC10 Q969S8 4/20 0.38
HDAC11 Q96DB2 4/20 0.38
HDAC8 Q9BY41 4/20 0.38
HDAC6 Q9UBN7 4/20 0.38
HDAC9 Q9UKV0 4/20 0.38
HDAC5 Q9UQL6 4/20 0.38
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL551283 0.90 ACACB (0.52) ACACBACACAHDAC3HDAC4HDAC1
SCHEMBL10170259 0.90 ACACB (0.52) ACACBACACAHDAC3HDAC4HDAC1
SCHEMBL10170263 0.89 ACACB (0.49) ACACBACACAHDAC3HDAC4HDAC1
SCHEMBL551034 0.89 ACACB (0.50) ACACBACACAP2RY12HDAC3HDAC4
SCHEMBL552034 0.89 ACACB (0.51) ACACBACACAHDAC3HDAC4HDAC1
SCHEMBL10169913 0.88 ACACB (0.54) ACACBACACANPC1TDP1LMNA
SCHEMBL10170420 0.88 ACACB (0.51) ACACBACACAHDAC3HDAC4HDAC1
SCHEMBL10169916 0.87 ACACB (0.54) ACACBACACAHDAC3HDAC4HDAC1
SCHEMBL10170368 0.87 ACACB (0.52) ACACBACACAHDAC3HDAC4HDAC1
SCHEMBL10170291 0.87 ACACB (0.53) ACACBACACANPC1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110570-B2 Modulators of acetyl-coenzyme A carboxylase and methods of use thereof CROPSOLUTION, INC. (US) 2012-02-07 US disclosed
US-8110570-B2 Modulators of acetyl-coenzyme A carboxylase and methods of use thereof CROPSOLUTION, INC. (US) 2012-02-07 US disclosed
US-20100009982-A1 Modulators of Acetyl-Coenzyme A Carboxylase and Methods of Use Thereof CROPSOLUTION, INC. 2010-01-14 US disclosed
US-20100009982-A1 Modulators of Acetyl-Coenzyme A Carboxylase and Methods of Use Thereof CROPSOLUTION, INC. 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009982-A1 Modulators of Acetyl-Coenzyme A Carboxylase and Methods of Use Thereof ACACA, ACAT1, ACACB ACACB 3/4885ACACA 1/4885P2RY12 4145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.